Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

PERSPECTIVE THERAPEUTICS, INC. (CATX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

PERSPECTIVE THERAPEUTICS, INC. (CATX), most recent 12 months reported: net loss $116.43M, free cash flow -$121.3M. Latest balance sheet on file: liquid cash $236.88M, total debt $1.6M, net cash $235.28M. From SEC filings. Others in Pharmaceutical Preparations: BOUNDLESS BIO, INC. · BeyondSpring Inc. · CalciMedica, Inc. · CAPRICOR THERAPEUTICS, INC. · CDT EQUITY INC. · Cingulate Inc. · Cellectar Biosciences, Inc. · CLIMB BIO, INC.

Stock screener

Watchlist